Membership
Interested in becoming a member? Discover the benefits of membership and join thousands of other IDD nurses who make our organization great. Join now and have access to more than 70 hours of FREE I/DD Education.
If you are member and close to your renewal date, renew your membership here. Do you need to create your personalized login? Create your username and password here.
Education
We offer more than 70 hours of developmental disability courses for members only! Learn more about DDNA's courseware offerings here.
Certification
Interested in certification in the specialty of IDD nursing? Read how to become a CDDN or DDC. Details on the certification page.
Looking for practice study material for the exam? Check out the certification exam practice questions.
Newsletters
Follow along with the latest in IDD news with informative articles written by and for nurses working in the field. DDNA offers a quarterly newsletter to members that contains must-read information. The most current version is available on the Newsletter page in a variety of formats, including a 'magazine' style "flipping book." View it now on the Newsletter page.
Newest Information
2nd Call for Member News/Articles for June Newsletter
May 21, 2013
DDNA is now
putting together the June newsletter. We need news and articles of interest to
DD nurses . . . like you! The newsletter is YOUR opportunity to share
information... View Full Post
Research done at the University of California Davis Medical Center have shown that minocycline treatment for 3 months in children with fragile X syndrome
(FXS) was associated with greater ... View Full Post
DDNA's Aspirational Standards of Developmental Disabilities Nursing Practice, is available in both print and eBook form (pdf) from our publication storefront. DDNA's "Position on Medication Management for Individuals with Intellectual and Developmental Disabilities" paper is available as a printed publication. Visit DDNA's publication storefront at http://www.lulu.com/spotlight/ddna for additional publications, including conference manuals and newsletters.
Study Shows Some Benefit from Minocycline Treatment in Chidren with FXS
May 21, 2013
FDA Safety Alert for Seizure Medication Potiga
May 21, 2013
The U.S. Food and Drug Administration (FDA) is warning the public
that the anti-seizure medication Potiga (ezogabine) can cause blue skin
discoloration and eye abnormalities characterized by
... View Full Post
DDNA Publications
Standards of DD Nursing Practice
Order the printed book or
eBook (pdf).
Med Management Position Paper
Order your printed book today.
More Publications